Molecular profiling is quickly becoming a critical tool in identifying genomic mutations that indicate a potential response to targeted cancer therapy. While most healthcare organizations are still outsourcing such testing, some are executing local strategies to bring capabilities in-house. In this workshop, speakers will discuss requirements for successfully setting up and implementing cancer molecular profiling in-house based on experience at a regional healthcare organization, USA Health, that serves a diverse population along the upper Gulf Coast. Faster turnaround time and better management of patient data are among advantages, as well as improved access to clinical trials, which are a big part of precision oncology programs but tend not to be broadly accessible within community practices where most cancer patients are treated.
Thuy Phung, MD, PhD is associate professor and medical director of molecular pathology & dermatopathology at the University of South Alabama. She has been spearheading efforts to enhance molecular diagnostics for cancer patients in underserved areas in the Gulf Coast region by establishing rapid single-gene testing as well as actionable, cost-effective next generation sequencing (NGS) assays. She is the lead author of Pediatric Dermatopathology, a comprehensive textbook in the field. Dr. Phung is passionate about global health. She co-founded the award-winning Vascular Anomalies Center in Ho Chi Minh City, Vietnam, which cares for thousands of underserved children with vascular birthmarks, and is leading efforts to establish molecular diagnostics for these disorders
Mr. Davis has more than 25 years of leadership experience in the life sciences, healthcare, and software fields. Previous roles have included Vice President of Market Development and Strategy at DNAnexus, head of Strategy and Market Development for Illumina focused on informatics, and the head of Healthcare Strategy and Business Development at Oracle